APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen Receptor (AR) Antagonist

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Androgen Receptor (AR) Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025184 pages

Choose your research edition.

Industry ResearchAndrogen Receptor (AR) Antagonist Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen Receptor (AR) Antagonist Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Androgen Receptor (AR) Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen Receptor (AR) Antagonist Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen Receptor (AR) Antagonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Androgen Receptor (AR) Antagonist market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Androgen Receptor (AR) Antagonist include Kaituo Pharmaceutical, Pfizer, Hengrui Medicine, Bayer, R&D Systems, Janssen Pharmaceuticals and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Androgen Receptor (AR) Antagonist market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Androgen Receptor (AR) Antagonist and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Androgen Receptor (AR) Antagonist sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Androgen Receptor (AR) Antagonist market size, projected growth trends, production technologies, key applications, and end-use industries.

Androgen Receptor (AR) Antagonist Segment by Company

Kaituo Pharmaceutical

Pfizer

Hengrui Medicine

Bayer

R&D Systems

Janssen Pharmaceuticals

Astellas Pharma

Androgen Receptor (AR) Antagonist Segment by Type

Steroidal AR Antagonists

Nonsteroidal AR Antagonists

Androgen Receptor (AR) Antagonist Segment by Application

Prostate Cancer

Breast Cancer

Others

Androgen Receptor (AR) Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen Receptor (AR) Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen Receptor (AR) Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen Receptor (AR) Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Androgen Receptor (AR) Antagonist market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Androgen Receptor (AR) Antagonist manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Androgen Receptor (AR) Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Androgen Receptor (AR) Antagonist in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Androgen Receptor (AR) Antagonist Industry Trends Table 2. Androgen Receptor (AR) Antagonist Industry Drivers Table 3. Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges Table 4. Androgen Receptor (AR) Antagonist Industry Restraints Table 5. Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Androgen Receptor (AR) Antagonist Sales by Manufacturers (K Tons) & (2021-2026) Table 8. Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers Table 9. Global Androgen Receptor (AR) Antagonist Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Androgen Receptor (AR) Antagonist Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Androgen Receptor (AR) Antagonist Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Androgen Receptor (AR) Antagonist Manufacturers, Product Type & Application Table 13. Global Androgen Receptor (AR) Antagonist Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Androgen Receptor (AR) Antagonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Steroidal AR Antagonists Table 17. Major Manufacturers of Nonsteroidal AR Antagonists Table 18. Global Androgen Receptor (AR) Antagonist Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 19. Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 20. Global Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 21. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2026) Table 22. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2027-2032) Table 23. Global Androgen Receptor (AR) Antagonist Revenue by Type 2021 VS 2025 VS 2032 (K Tons) Table 24. Global Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (K Tons) Table 25. Global Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (K Tons) Table 26. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2026) Table 27. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Prostate Cancer Table 29. Major Manufacturers of Breast Cancer Table 30. Major Manufacturers of Others Table 31. Global Androgen Receptor (AR) Antagonist Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 32. Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 33. Global Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 34. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2026) Table 35. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2027-2032) Table 36. Global Androgen Receptor (AR) Antagonist Revenue by Application 2021 VS 2025 VS 2032 (K Tons) Table 37. Global Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (K Tons) Table 38. Global Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (K Tons) Table 39. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2026) Table 40. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2027-2032) Table 41. Global Androgen Receptor (AR) Antagonist Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Table 42. Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026) & (K Tons) Table 43. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021-2026) Table 44. Global Androgen Receptor (AR) Antagonist Sales Forecasted by Region (2027-2032) & (K Tons) Table 45. Global Androgen Receptor (AR) Antagonist Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 47. North America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 48. North America Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 49. Europe Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 50. Europe Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 51. Europe Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 52. Asia Pacific Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 53. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 54. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 55. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Tons) Table 56. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 57. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 58. Global Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Androgen Receptor (AR) Antagonist Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Androgen Receptor (AR) Antagonist Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021-2026) Table 62. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2027-2032) Table 63. Kaituo Pharmaceutical Company Information Table 64. Kaituo Pharmaceutical Business Overview Table 65. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio Table 67. Kaituo Pharmaceutical Recent Development Table 68. Pfizer Company Information Table 69. Pfizer Business Overview Table 70. Pfizer Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Pfizer Androgen Receptor (AR) Antagonist Product Portfolio Table 72. Pfizer Recent Development Table 73. Hengrui Medicine Company Information Table 74. Hengrui Medicine Business Overview Table 75. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio Table 77. Hengrui Medicine Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bayer Androgen Receptor (AR) Antagonist Product Portfolio Table 82. Bayer Recent Development Table 83. R&D Systems Company Information Table 84. R&D Systems Business Overview Table 85. R&D Systems Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio Table 87. R&D Systems Recent Development Table 88. Janssen Pharmaceuticals Company Information Table 89. Janssen Pharmaceuticals Business Overview Table 90. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio Table 92. Janssen Pharmaceuticals Recent Development Table 93. Astellas Pharma Company Information Table 94. Astellas Pharma Business Overview Table 95. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (K Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio Table 97. Astellas Pharma Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Androgen Receptor (AR) Antagonist Distributors List Table 101. Androgen Receptor (AR) Antagonist Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Androgen Receptor (AR) Antagonist Product Image Figure 2. Global Androgen Receptor (AR) Antagonist Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgen Receptor (AR) Antagonist Market Size (2021-2032) & (US$ Million) Figure 4. Global Androgen Receptor (AR) Antagonist Sales (2021-2032) & (K Tons) Figure 5. Global Androgen Receptor (AR) Antagonist Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Androgen Receptor (AR) Antagonist Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Steroidal AR Antagonists Image Figure 9. Nonsteroidal AR Antagonists Image Figure 10. Global Androgen Receptor (AR) Antagonist Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 11. Global Androgen Receptor (AR) Antagonist Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2032) Figure 13. Global Androgen Receptor (AR) Antagonist Revenue by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 14. Global Androgen Receptor (AR) Antagonist Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2032) Figure 16. Prostate Cancer Image Figure 17. Breast Cancer Image Figure 18. Others Image Figure 19. Global Androgen Receptor (AR) Antagonist Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 20. Global Androgen Receptor (AR) Antagonist Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2032) Figure 22. Global Androgen Receptor (AR) Antagonist Revenue by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 23. Global Androgen Receptor (AR) Antagonist Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2032) Figure 25. North America Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 26. North America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2032) Figure 27. U.S. Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 28. Canada Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 29. Mexico Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 30. Europe Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 31. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2032) Figure 32. Germany Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 33. France Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 34. U.K. Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 35. Italy Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 36. Netherlands Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 37. Asia Pacific Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 38. Asia Pacific Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2032) Figure 39. China Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 40. Japan Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 41. South Korea Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 42. Southeast Asia Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 43. India Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 44. Australia Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 45. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 46. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021-2032) Figure 47. Brazil Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 48. South Africa Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 49. Saudi Arabia Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 50. Turkey Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 51. Argentina Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 52. UAE Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 53. Egypt Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 54. Chile Androgen Receptor (AR) Antagonist Sales and Growth Rate (2021-2032) & (K Tons) Figure 55. Global Androgen Receptor (AR) Antagonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Figure 58. North America Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Figure 60. Europe Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Androgen Receptor (AR) Antagonist Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Androgen Receptor (AR) Antagonist Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
Applications
  • Prostate Cancer
  • Breast Cancer
  • Others
Companies covered
  • Kaituo Pharmaceutical
  • Pfizer
  • Hengrui Medicine
  • Bayer
  • R&D Systems
  • Janssen Pharmaceuticals
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Androgen Receptor (AR) Antagonist Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Androgen Receptor (AR) Antagonist Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Androgen Receptor (AR) Antagonist Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Androgen Receptor (AR) Antagonist Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Androgen Receptor (AR) Antagonist Market Dynamics
  1. 2.1 Androgen Receptor (AR) Antagonist Industry Trends
  2. 2.2 Androgen Receptor (AR) Antagonist Industry Drivers
  3. 2.3 Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges
  4. 2.4 Androgen Receptor (AR) Antagonist Industry Restraints
3 Androgen Receptor (AR) Antagonist Market by Manufacturers
  1. 3.1 Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Androgen Receptor (AR) Antagonist Sales by Manufacturers (2021-2026)
  3. 3.3 Global Androgen Receptor (AR) Antagonist Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Androgen Receptor (AR) Antagonist Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Androgen Receptor (AR) Antagonist Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Androgen Receptor (AR) Antagonist Manufacturers, Product Type & Application
  7. 3.7 Global Androgen Receptor (AR) Antagonist Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Androgen Receptor (AR) Antagonist Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Androgen Receptor (AR) Antagonist Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Androgen Receptor (AR) Antagonist Tier 1, Tier 2, and Tier 3
4 Androgen Receptor (AR) Antagonist Market by Type
  1. 4.1 Androgen Receptor (AR) Antagonist Type Introduction
  2. 4.1.1 Steroidal AR Antagonists
  3. 4.1.2 Nonsteroidal AR Antagonists
  4. 4.2 Global Androgen Receptor (AR) Antagonist Sales by Type
  5. 4.2.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  7. 4.2.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2032)
  8. 4.3 Global Androgen Receptor (AR) Antagonist Revenue by Type
  9. 4.3.1 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  11. 4.3.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2032)
5 Androgen Receptor (AR) Antagonist Market by Application
  1. 5.1 Androgen Receptor (AR) Antagonist Application Introduction
  2. 5.1.1 Prostate Cancer
  3. 5.1.2 Breast Cancer
  4. 5.1.3 Others
  5. 5.2 Global Androgen Receptor (AR) Antagonist Sales by Application
  6. 5.2.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 5.2.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2032)
  9. 5.3 Global Androgen Receptor (AR) Antagonist Revenue by Application
  10. 5.3.1 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  12. 5.3.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2032)
6 Global Androgen Receptor (AR) Antagonist Sales by Region
  1. 6.1 Global Androgen Receptor (AR) Antagonist Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2032)
  3. 6.2.1 Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026)
  4. 6.2.2 Global Androgen Receptor (AR) Antagonist Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Androgen Receptor (AR) Antagonist Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Androgen Receptor (AR) Antagonist Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Androgen Receptor (AR) Antagonist Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Androgen Receptor (AR) Antagonist Revenue by Region
  1. 7.1 Global Androgen Receptor (AR) Antagonist Revenue by Region
  2. 7.1.1 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Androgen Receptor (AR) Antagonist Revenue by Region (2021-2026)
  4. 7.1.3 Global Androgen Receptor (AR) Antagonist Revenue by Region (2027-2032)
  5. 7.1.4 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Androgen Receptor (AR) Antagonist Revenue (2021-2032)
  8. 7.2.2 North America Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Androgen Receptor (AR) Antagonist Revenue (2021-2032)
  11. 7.3.2 Europe Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Androgen Receptor (AR) Antagonist Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Androgen Receptor (AR) Antagonist Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Androgen Receptor (AR) Antagonist Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Kaituo Pharmaceutical
  2. 8.1.1 Kaituo Pharmaceutical Company Information
  3. 8.1.2 Kaituo Pharmaceutical Business Overview
  4. 8.1.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio
  6. 8.1.5 Kaituo Pharmaceutical Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Androgen Receptor (AR) Antagonist Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Hengrui Medicine
  14. 8.3.1 Hengrui Medicine Company Information
  15. 8.3.2 Hengrui Medicine Business Overview
  16. 8.3.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio
  18. 8.3.5 Hengrui Medicine Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bayer Androgen Receptor (AR) Antagonist Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 R&D Systems
  26. 8.5.1 R&D Systems Company Information
  27. 8.5.2 R&D Systems Business Overview
  28. 8.5.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio
  30. 8.5.5 R&D Systems Recent Developments
  31. 8.6 Janssen Pharmaceuticals
  32. 8.6.1 Janssen Pharmaceuticals Company Information
  33. 8.6.2 Janssen Pharmaceuticals Business Overview
  34. 8.6.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio
  36. 8.6.5 Janssen Pharmaceuticals Recent Developments
  37. 8.7 Astellas Pharma
  38. 8.7.1 Astellas Pharma Company Information
  39. 8.7.2 Astellas Pharma Business Overview
  40. 8.7.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio
  42. 8.7.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Androgen Receptor (AR) Antagonist Value Chain Analysis
  2. 9.1.1 Androgen Receptor (AR) Antagonist Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Androgen Receptor (AR) Antagonist Production Mode & Process
  6. 9.2 Androgen Receptor (AR) Antagonist Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Androgen Receptor (AR) Antagonist Distributors
  9. 9.2.3 Androgen Receptor (AR) Antagonist Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst